CCL20 expression was a risk factor and significantly negatively correlated with overall survival in cervical squamous cell carcinoma, kidney renal papillary cell carcinoma (KIRP), uveal melanoma, and lung adenocarcinoma (LUAD) (Fig. 8B). This evidence concerns the gene CCL20 and lung adenocarcinoma.